文献速递心血管技术与安全

COVID-19对美国与其他国家心血管检查的影响对比

Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World.
PubMed 文献 · JACC Cardiovasc Imaging · 2021-06-16

基于108个国家909家机构(含美国40州155家)的多国注册研究显示,2020年4月美国心血管检查量较2019年3月基线下降68%,与非美国机构63%相近(p=0.237),但美国侵入性冠状动脉造影降幅更大(69% vs 53%,p<0.001);美国东北部降幅76%、中西部74%高于南部62%和西部44%,多变量分析显示COVID-19患病率、人员调配、门诊中心和城市中心与美国机构检查量更大降幅相关。

要点

  • 2020年4月美国心血管检查量较2019年3月下降68%,与非美国机构63%相近(p=0.237)。
  • 美国侵入性冠状动脉造影降幅69%大于非美国机构53%(p<0.001)。
  • 美国东北部降幅76%、中西部74%高于南部62%和西部44%。

核心结论

  • 大流行早期美国心血管检查量显著下降,且美国各地区间差异显著;检查量下降与COVID-19患病率的关联提示需主动维持受疫情影响地区心血管检查的可及性。

研究设计与样本

  • 多国注册研究(INCAPS-COVID),纳入108个国家909家机构(含美国40州155家),获取2020年4月数据并与2019年3月基线操作量比较。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-U.S. institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic.

BACKGROUND: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality.

METHODS: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States.

RESULTS: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis.

CONCLUSIONS: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Hirschfeld CB, Shaw LJ, Williams MC, et al. Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World. JACC Cardiovasc Imaging. 2021. PMID: 34147434. doi:10.1016/j.jcmg.2021.03.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。